KLS Keeping Law Simple Legislation in plain English

Straight-ahead summaries built from the official bill text. We keep the source links front and center and leave the decision up to you.

Back to Oregon

HB2103 • 2025

Directs the State Board of Pharmacy to adopt rules to classify xylazine as a Schedule IV controlled substance.

Directs the State Board of Pharmacy to adopt rules to classify xylazine as a Schedule IV controlled substance.

Passed Legislature

This bill passed both chambers and reached final enrollment, even if later executive action is not shown here.

Sponsor
Representative Osborne
Last action
2025-06-27
Official status
In House Committee
Effective date
Not listed

Plain English Breakdown

The plain English breakdown is still being put together. The official documents below are already here.

Bill History

  1. 2025-06-27 House

    In committee upon adjournment.

  2. 2025-01-17 House

    Referred to Behavioral Health and Health Care.

  3. 2025-01-13 House

    First reading. Referred to Speaker's desk.

Official Summary Text

Digest: The Act tells the State Board of Pharmacy to classify xylazine as a Schedule IV controlled substance. (Flesch Readability Score: 60.1).
Directs the State Board of Pharmacy to adopt rules to classify xylazine as a Schedule IV controlled substance.
Relating to: Relating to xylazine.
Current location: In House Committee